Drug development plans that aren’t fully aligned across clinical, regulatory, and operational teams introduce costly delays, rework, and regulatory risk. Certara’s integrated planning approach helps you break down silos and build coordinated, data-driven strategies that strengthen milestones from early development through regulatory engagement.
Integrate your drug development strategy with Certara
See how strategic alignment across functions accelerates decisions and reduces risk.
With Certara experts you get:
Cross-functional alignment across clinical, regulatory, and operational teams
Data-driven development strategies that strengthen key milestones
Improved submission readiness and regulatory confidence
Clearer assumptions, timelines, and evidence plans across your program
Why you shouldn’t miss this opportunity
Even small efficiency gains can create significant enterprise value. Research shows that just a 3% increase in process efficiency can represent up to $300 million in potential savings per drug.
This session will help you evaluate where earlier, better-informed decisions can reduce waste and unlock value across your portfolio.
- Identify inefficiencies that may be costing time and capital
- Turn fragmented processes into measurable efficiency gains
- Optimize resources toward your highest-value programs
- Strengthen regulatory readiness through aligned evidence planning
- Accelerate innovative medicines to patients with greater confidence
Why choose Certara for Early Development?
700
drug development scientists and experts to advance your program leveraging tech-enabled decision-making
>90
of all novel drugs approved by the US FDA since 2014 were supported by Certara tech-enabled solutions
400
MD, PharmD, and PhD drug development scientists
7
of Certara's scientists are recognized as top 2% most cited
